Identification of early predictive imaging biomarkers and their relationship to serological angiogenic markers in patients with ovarian cancer with re

dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI)

"CONCLUSIONS: Imaging markers have a potential role in early prediction of disease progression in patients with residual ovarian cancer and may supplement current measures of progression. The correlation of DCE-MRI and serological biomarkers suggests that tumour angiogenesis affects these markers through common biological means and warrants further investigation."